Topical administration of a connexin43-based peptide augments healing of chronic neuropathic diabetic foot ulcers: A multicenter, randomized trial

Keyphrases

• Healing 100%
• Ulcer 100%
• Neuropathic Ulcer 100%
• Connexin 43 (Cx43) 100%
• Multicenter Randomized Trial 100%
• Topical Administration 100%
• Re-epithelialization 75%
• Standard of Care 50%
• Median Time 50%
• Chronic Diabetic Foot Ulcers 50%
• Therapeutic Strategies 25%
• C-terminus 25%
• Care Protocol 25%
• Peptidomimetics 25%
• Carboxyl Terminus 25%
• Adverse Events 25%
• Patients with Diabetes 25%
• Prospective Randomized Trial 25%
• Immunogenic 25%
• Topical Application 25%
• Connexin 25%
• Treatment Protocol 25%
• Immunogenicity 25%
• Treatment-related 25%
• Diabetic Foot Ulcer 25%
• Multicenter Clinical Trial 25%
• Non-healing 25%
• Dermal Wound Healing 25%
• Treatment-related Adverse Events 25%
• Junctional Proteins 25%
• Ulcer Area 25%

Medicine and Dentistry

• Ulcer 100%
• Diabetic Foot Ulcer 100%
• Topical Drug Administration 100%
• Epithelization 60%
• Carboxy Terminal Sequence 40%
• Adverse Event 40%
• Clinical Trial 20%
• Foot Ulcer 20%
• Wound 20%
• Diabetes 20%
• Wound Healing 20%
• Immunogenicity 20%
• Gap Junction Protein 20%

Pharmacology, Toxicology and Pharmaceutical Science

• foot ulcer, diabetic 100%
• Ulcer 100%
• Adverse Event 40%
• Clinical Trial 20%
• Wound 20%
• Wound Healing 20%
• Gap Junction Protein 20%
• Immunogenicity 20%
• Foot Ulcer 20%